Study identifies possible link between antibiotic use and breast cancer growth
Researchers have investigated how disrupting a healthy balance of bacteria in the gut impacts breast cancer growth in mice.
Pharmaceuticals
CinnaGen protein subunit Covid-19 vaccine Phase III results likely within two months
Race to be the first widely distributed protein subunit Covid-19 vaccine heats up with Vaxine...
Billionaires are betting on anti-ageing research, but can ageing really be cured?
Amazon founder Jeff Bezos has reportedly invested in Altos Labs, a new anti-ageing start-up that...
Covid-19 vaccine boosters not widely needed, say top FDA and WHO scientists
The comments come as the US government gears up to roll out vaccine booster shots...
Insurers to squeeze JAK inhibitor access in chronic conditions after FDA safety warning
A recent safety warning added by the FDA to JAK inhibitors approved for inflammatory conditions...
Algae proteins and optogenetics: a vision of the future
The vision of a completely blind man has been partially restored using light-sensing proteins found in algae.
Multiple myeloma: first bispecific mAb to secure r/r approval will have biggest market bite
Market latecomers will likely struggle to demonstrate value-added edge so early strategic decisions are critical.
ExeVir Q&A: the llama-derived antibody that could fight Covid-19
The company’s lead antibody, XVR011, is currently being trialled in healthy individuals and hospitalised Covid-19 patients.
Leading regenerative medicine advocacy group leverages GlobalData’s datasets to highlight a record year
The Alliance for Regenerative Medicine’s report reveals the data behind a “year of firsts and records” for the sector.
AstraZeneca and EU reach settlement over delayed Covid-19 vaccine doses
The agreement puts an end to the legal dispute initiated by the EU against AstraZeneca earlier this year.
Has Covid-19 exposed the weakness of the US pharma supply chain?
A recent study revealed that over 80% of APIs for essential medicines across key therapeutic areas have no US manufacturing source.
